TCW Group’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-1,019,452
Closed -$217M 779
2014
Q4
$217M Buy
1,019,452
+5,092
+0.5% +$1.01M 0.91% 36
2014
Q3
$181M Buy
1,014,360
+284,757
+39% +$47.3M 0.73% 39
2014
Q2
$123M Sell
729,603
-984,296
-57% -$153M 0.51% 63
2014
Q1
$213M Sell
1,713,899
-28,174
-2% -$3.43M 0.88% 28
2013
Q4
$194M Sell
1,742,073
-182,063
-9% -$17.4M 0.82% 37
2013
Q3
$174M Sell
1,924,136
-50,762
-3% -$4.56M 0.8% 40
2013
Q2
$166M Buy
+1,974,898
New +$205M 0.82% 35

Other funds holding AGN

TCW Group's AGN Position: Q1 2015 in Review

TCW Group sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 1,019,452 shares — an estimated $217M sold.

TCW Group first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $217M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • TCW Group reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • TCW Group sold 1,019,452 Allergan Inc shares in Q1 2015, an estimated $217M.
  • TCW Group first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • TCW Group's Allergan Inc position peaked at $217M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on TCW Group's 13F filing for Q1 2015, filed 13 May 2015.